The SARS-CoV-2 spike protein induces lung cancer migration and invasion in a TLR2-dependent manner
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
Cancer communications (London, England) - 44(2024), 2 vom: 13. Feb., Seite 273-277 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kim, Mi-Jeong [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Letter |
|---|
| Anmerkungen: |
Date Completed 21.02.2024 Date Revised 13.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/cac2.12485 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361998244 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361998244 | ||
| 003 | DE-627 | ||
| 005 | 20240313233625.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/cac2.12485 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1326.xml |
| 035 | |a (DE-627)NLM361998244 | ||
| 035 | |a (NLM)37702496 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kim, Mi-Jeong |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The SARS-CoV-2 spike protein induces lung cancer migration and invasion in a TLR2-dependent manner |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.02.2024 | ||
| 500 | |a Date Revised 13.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a spike protein, SARS-CoV-2 |2 NLM | |
| 650 | 7 | |a Spike Glycoprotein, Coronavirus |2 NLM | |
| 650 | 7 | |a Toll-Like Receptor 2 |2 NLM | |
| 650 | 7 | |a TLR2 protein, human |2 NLM | |
| 700 | 1 | |a Kim, Ji Young |e verfasserin |4 aut | |
| 700 | 1 | |a Shin, Ji Hye |e verfasserin |4 aut | |
| 700 | 1 | |a Son, Juhee |e verfasserin |4 aut | |
| 700 | 1 | |a Kang, Yeeun |e verfasserin |4 aut | |
| 700 | 1 | |a Jeong, Soo-Kyung |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Duk-Hwan |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Kyun-Hwan |e verfasserin |4 aut | |
| 700 | 1 | |a Chun, Eunyoung |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Ki-Young |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer communications (London, England) |d 2018 |g 44(2024), 2 vom: 13. Feb., Seite 273-277 |w (DE-627)NLM28410809X |x 2523-3548 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2024 |g number:2 |g day:13 |g month:02 |g pages:273-277 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/cac2.12485 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2024 |e 2 |b 13 |c 02 |h 273-277 | ||